Sample information | HD | Type-1 CKD | Type-2 CKD | Type-3 CKD | |
      Total sample number | 82 | 145 | 32 | 123 | |
      Male/female | 44/38 | 106/39 | 21/11 | 70/53 | |
      Age (average ± SD) | 44.1 ± 11.2 | 66.0 ± 10.4 | 76.0 ± 9.8 | 62.0 ± 11.7 | |
Alpha analysis (antibody level) | DIDO1-Ab | FOXJ2-Ab | CPSF2-Ab | Â | |
HD | Average | 3166 | 1300 | 914 | Â |
SD | 1423 | 517 | 298 | Â | |
Cutoff value | 6012 | 2334 | 1509 | Â | |
Positive no. | 6 | 3 | 3 | Â | |
Positive rate (%) | 7.3% | 3.7% | 3.7% | Â | |
Type 1-CKD | Average | 6805 | 2141 | 939 | Â |
SD | 4675 | 1330 | 382 | Â | |
Positive no. | 63 | 41 | 7 | Â | |
Positive rate (%) | 43.4% | 28.3% | 4.8% | Â | |
P (vs HD) | < 0.0001 | < 0.0001 | 0.579 |  | |
Type 2-CKD | Average | 6693 | 2245 | 1020 | Â |
SD | 3347 | 930 | 281 | Â | |
Positive no. | 12 | 11 | 2 | Â | |
Positive rate (%) | 37.5% | 34.4% | 6.3% | Â | |
P (vs HD) | < 0.0001 | < 0.0001 | 0.081 |  | |
Type 3-CKD | Average | 5264 | 1770 | 936 | Â |
SD | 2161 | 829 | 421 | Â | |
Positive no. | 33 | 17 | 10 | Â | |
Positive rate (%) | 26.8% | 13.8% | 8.1% | Â | |
P (vs HD) | < 0.0001 | < 0.0001 | 0.656 |  |